Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

Largest physician specialty group endorses Medicare for all

The American College of Physicians, which represents 159,000 internists in the U.S., has endorsed a single-payer American healthcare system.

Thumbnail

Trump worries about healthcare poll, regrets enacting vaping restrictions

HHS Secretary Alex Azar took some heat from President Trump after a recent poll showed Democrats leading when it came to the issue of healthcare.

 

Thumbnail

Medical researchers must understand risks associated with AI

AI is poised to change the healthcare industry forever—but risks remain that researchers must take seriously.

Thumbnail

Hospital, health system model changes drove M&A in 2019

Changing models across hospitals and health systems helped drive mergers and acquisition activity in 2019, according to a new report from Kaufman Hall.

Thumbnail

Without individual mandate, the ACA chugs along

The Affordable Care Act has remained strong despite the lack of an individual mandate, which was effectively stripped in the 2018 budget by Republicans.

Thumbnail

UPMC designates $1B investment in life sciences

The innovation and venture capital arm of University of Pittsburgh Medical Center (UPMC) is planning to invest $1 billion into life sciences to develop new drugs, diagnostics and devices over the next four years.

Thumbnail

More healthcare M&A on the horizon in 2020

Executives in the healthcare space are expecting more M&A activity in 2020 compared to 2019, according to a new outlook from KPMG. 

Thumbnail

How drugmakers are working to get paid for their most expensive treatments

New medical treatments such as gene therapies come with a high price tag up to six figures, and drugmakers are working hard to ensure they can get reimbursed for these medicines in creative ways.

Displaying 849 - 856 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup